Clostridium difficile infection in a French university hospital: Eight years of prospective surveillance study
- PMID: 27281101
- PMCID: PMC4907679
- DOI: 10.1097/MD.0000000000003874
Clostridium difficile infection in a French university hospital: Eight years of prospective surveillance study
Erratum in
-
Erratum: Medicine, Volume 95, Issue 23: Erratum.Medicine (Baltimore). 2016 Jul 18;95(28):e0916. doi: 10.1097/01.md.0000489580.04709.16. eCollection 2016 Jul. Medicine (Baltimore). 2016. PMID: 31265603 Free PMC article.
Abstract
The epidemiology of Clostridium difficile infection (CDI) has changed with an increase in incidence and severity. Prospective surveillance was therefore implemented in a French university hospital to monitor the characteristics of patients at risk and to recognize local trends. Between 2007 and 2014, all hospitalized patients (≥18 years) with CDI were included. During the survey, the mean incidence rate of CDI was 2.9 per 10,000 hospital-days. In all, 590 patients were included. Most of the episodes were healthcare-associated (76.1%). The remaining cases were community-acquired (18.1%) and unknown (5.9%). The comparison with healthcare-associated cases showed that the community-acquired group had a lower rate of antimicrobial exposure (P < 0.001), proton pump inhibitor (P < 0.001), and immunosuppressive drugs (P = 0.02). Over the study period, death occurred in 61 patients (10.3%), with 18 (29.5%) being related to CDI according to the physician in charge of the patient. Active surveillance of CDI is required to obtain an accurate picture of the real dimensions of CDI.
Conflict of interest statement
Nagham Khanafer received a PhD grant from Sanofi Pasteur, nonfinancial support (travel expenses) from Alere and Sanofi Pasteur, and lecture fees from Astellas. Philippe Vanhems received scientific grants from Sanofi Pasteur, Sanofi MSD, and Anios, and personal fees from Sanofi Pasteur, BioMérieux, GSK, and Sanofi MSD. The other authors have no conflicts of interest to declare.
No author has a conflict of interest associated with the pulication of this work and all authors meet standard criteria for authorship.
Figures



References
-
- Martin M, Zingg W, Knoll E, et al. On behlaf of the PROHIBIT study group. National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review. J Hosp Infect 2014; 87:212–219. - PubMed
-
- Feuerstadt P, Das R, Brandt LJ. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008. Am J Gastroenterol 2014; 109:1265–1276. - PubMed
-
- Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346:334–339. - PubMed
-
- Kim J, Kang JO, Kim H, et al. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 2013; 19:521–527. - PubMed
-
- Muto CA, Blank MK, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis 2007; 45:1266–1273. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources